This conference has been withdrawn from the 2020 conference schedule
As you are aware, coronavirus is having a global impact and the World Health Organization and the Centers for Disease Control have instituted recommendations that include social distancing and cancelling conferences and large gatherings. Since safety of our attendees is always GRC's highest priority, the GRC Board of Trustees has decided to withdraw this conference and it will be rescheduled for 2022. This decision was made out of an abundance of caution and to alleviate the concerns of our conference communities that are scheduled to meet in this timeframe.
This meeting will allow opportunity for discussion of recent results relating the activities of all transglutaminase enzymes with cardiovascular diseases, neurological diseases, cancer and signalling disorders, celiac disease and inflammation, fibrosis and remodelling disorders. Additionally, this meeting will focus on emerging diseases associated with this class of enzymes, and new methods for their investigation.